Shopping Cart
- Remove All
- Your shopping cart is currently empty
PCSK9-IN-31 (Compound WX002) is an orally effective PCSK9 inhibitor. It has been shown to reduce levels of low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in a high cholesterol-fed rat model.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | PCSK9-IN-31 (Compound WX002) is an orally effective PCSK9 inhibitor. It has been shown to reduce levels of low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in a high cholesterol-fed rat model. |
Molecular Weight | 406.48 |
Formula | C23H26N4O3 |
Cas No. | 2247649-76-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.